Friday, July 10, 2026

pharma · Chronic Hepatitis B

Sun Yat-sen University

Third Affiliated Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Chronic Hepatitis B. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) t

CN HQ
3,680 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
3,680
Programs
1
Drugs
2
Patents
0
Clinical program

Peginterferon alfa

Approved · small molecule · Chronic Hepatitis B

Peginterferon alfa for Chronic Hepatitis B is a Approved program (small_molecule) at Third Affiliated Hospital, Sun Yat-Sen University with 1 ClinicalTrials.gov record(s).

Internal code 3rd-SYSU-I-Cure

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Third Affiliated Hospital, Sun Yat-Sen University
Phase
Approved
Modality
small_molecule
Indication
Chronic Hepatitis B
Status
active
Trials
1